专家笔谈

肌活检在特发性炎性肌病诊断和临床分型中的价值

  • 卢昕 ,
  • 张立宁
展开
  • 中日友好医院风湿免疫科, 北京 100029

收稿日期: 2018-10-15

  网络出版日期: 2018-12-17

本文引用格式

卢昕 , 张立宁 . 肌活检在特发性炎性肌病诊断和临床分型中的价值[J]. 北京大学学报(医学版), 2018 , 50(6) : 949 -951 . DOI: 10.19723/j.issn.1671-167X.2018.06.001

参考文献

[1] Bohan A, Peter JB . Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975,292(7):344-347.
[2] Bohan A, Peter JB . Polymyositis and dermatomyositis (second of two parts)[J]. N Engl J Med, 1975,292(8):403-407.
[3] Venalis P, Lundberg IE . Immune mechanisms in polymyositis and derrnatomyositis and potential targets for therapy[J]. Rheumatology (Oxford), 2014,53(3):397-405.
[4] Dalakas MC . Inflammatory muscle diseases[J]. N Engl J Med, 2015,372(18):1734-1747.
[5] Lu X, Peng Q, Wang G . Discovery of new biomarkers of idiopathic inflammatory myopathy[J]. Clin Chim Acta, 2015,444:117-125.
[6] Dalakas M . Polymyositis, dermatomyositis, and inclusion-body myositis[J]. N Engl J Med, 1991,325(21):1487-1498.
[7] Tanimoto K, Nakano K, Kano S , et al. Classification criteria for polymyositis and dermatomyositis[J]. J Rheumatol, 1995,22(4):668-674.
[8] Targoff I, Miller F, Medsger T , et al. Classification criteria for the idiopathic inflammatory myopathies[J]. Curr Opin Rheumatol, 1997,9(6):527-535.
[9] Dalakas MC, Hohlfeld R . Polymyositis and dermatomyositis[J]. Lancet, 2003,362(9388):971-982.
[10] Hoogendijk JE, Amato AA, Lecky BR , et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands[J]. Neuromuscul Disord, 2004,14(5):337-345.
[11] DeBleecker JL, Lundberg IE, De Visser M . 193rd ENMC Myositis Muscle Biopsy Study Group. 193rd ENMC International Workshop Pathology Diagnosis of Idiopathic Inflammatory Myopathies 30 November-2 December 2012, Naarden, the Netherlands[J]. Neuromuscul Disord, 2013,23(11):945-951.
[12] DeBleecker JL, De Paepe B, Aronica E , et al. 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part Ⅱ 28-30 March 2014, Naarden, The Netherlands[J]. Neuromuscul Disord, 2015,25(3):268-272.
[13] De Bleecker JL, Vervaet V , Van den Bergh P. Necrotizing myopathy with microvascular deposition of the complement membrane attack complex[J]. Clin Neuropathol, 2004,23(2):76-79.
[14] Takada T, Hirakata M, Suwa A , et al. Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies[J]. Mod Rheumatol, 2009,19(2):156-164.
[15] Christopher-Stine L, Casciola-Rosen LA, Hong G , et al. A novel autoantibody recognizing 200-kD and 100-kD proteins is associated with an immune-mediated necrotizing myopathy[J]. Arthritis Rheum, 2010,62(9):2757-2766.
[16] Ge Y, Lu X, Peng Q , et al. Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme a reductase antibodies in Chinese patients with idiopathic inflammatory myopathies[J]. PLoS One, 2015,10(10):e0141616.
[17] Allenbach Y , DrouotL, RigoletA, et al. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin[J]. Medicine (Baltimore), 2014,93(3):150-157.
[18] Wang L, Liu L, Hao H , et al. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients[J]. Neuromuscul Disord, 2014,24(4):335-341.
[19] Allenbach Y, Mammen AL, Benveniste O , et al. 224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies, The Netherlands, 14-16 October 2016[J]. Neuromuscul Disord, 2018,28(1):87-99.
[20] Van der Meulen MF, Bronner M, Hoogendijk JE , et al. Polymyositis: a diagnostic entity reconsidered[J]. Neurology, 2003,61(3):316-321.
[21] Kishi T, Rider LG, Pak K , et al. Association of anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibodies with DRB1 *07:01 and severe myositis in juvenile myositis patients [J]. Arthritis Care Res (Hoboken), 2017,69(7):1088-1094.
[22] Lundberg IE, Tj?rnlund A, Bottai M , et al. European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups[J]. Arthritis Rheumatol, 2017,69(12):2271-2282.
文章导航

/